Answer :
Final answer:
Samples enable testing new medications on patients, while clinical trials are vital for FDA compliance. Non-clinical laboratory studies precede clinical investigations for IND applications.
Explanation:
Samples allow the provider to introduce a new medication to a patient to determine tolerance before a full prescription. These samples permit an immediate loading dose to be administered, aiding in the evaluation process.
Clinical trials play a crucial role in testing pharmaceuticals to meet FDA requirements. Participants in clinical trials may receive investigational drugs to assess effectiveness and safety.
Non-clinical laboratory studies are essential before clinical investigations begin for Investigational New Drug Applications (IND), ensuring thorough preclinical evaluation.
Learn more about Introduction and evaluation of new medications here:
https://brainly.com/question/47844784
